Search Results 1-10 of 15937 for B%20cell%20lymphomas

  1. Cutaneous B-cell lymphoma - Overview - Mayo Clinic

    Learn about this type of cancer that starts in the white blood cells and affects the skin. Treatment options include surgery, radiation and chemotherapy.

  2. Non-Hodgkin's lymphoma - Symptoms and causes - Mayo Clinic

    Diffuse large B-cell lymphoma and follicular lymphoma are among the most common subtypes. The other general category of lymphoma is Hodgkin's lymphoma ...

  3. Diffuse Large B Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Biological therapies, such as lenalidomide, may stimulate or suppress the immune system in different ways and stop cancer cells from growing. Drugs used in ...

  4. Cutaneous B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab ...

  5. Overview - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    The Slager B-Cell Lymphoproliferative Disorders Lab at Mayo Clinic studies the genetic epidemiology of chronic lymphocytic leukemia (CLL), monoclonal B-cell ...

  6. A Study to Determine the Outcomes of Patients With Localized B Cell Lymphoblastic Lymphoma (B-LLy) When Treated With Standard Risk B-ALL Therapy - Mayo Clinic

    AALL1731 is a group-wide risk-stratified trial for children with newly diagnosed B-ALL and localized B-lymphoblastic lymphoma (B-LLy) that will test if the ...

  7. Lymphoma - Symptoms and causes - Mayo Clinic

    Types · Chronic lymphocytic leukemia · Cutaneous B-cell lymphoma · Cutaneous T-cell lymphoma · Hodgkin lymphoma (Hodgkin disease) · Non-Hodgkin's lymphoma ...

  8. Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients with Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma · Share · Facebook · Twitter.

  9. A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma - Mayo Clinic

    ... B-cell non-Hodgkin lymphoma (NHL) subtypes of diffuse large B-cell lymphoma (DLBCL) and Grade 3 follicular lymphoma (FL3). Additionally, the pharmacokinetic ...

  10. Axi-cel treatment for B-cell lymphoma provides real-world outcomes comparable to ZUMA-1 trial data - Mayo Clinic

    In a study of axicabtagene ciloleucel (axi-cel) CAR-T cell therapy for relapsed or refractory aggressive B-cell lymphoma, 30-day responses were comparable ...